Moxifloxacin Hydrochloride Patent Expiration
Moxifloxacin Hydrochloride is Used for treating bacterial infections in patients. It was first introduced by Bayer Healthcare Pharmaceuticals Inc
Moxifloxacin Hydrochloride Patents
Given below is the list of patents protecting Moxifloxacin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avelox | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Bayer Hlthcare |
| Avelox | US5849752 | Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification |
Dec 05, 2016
(Expired) | Bayer Hlthcare |
| Avelox | US6610327 | Pharmaceutical moxifloxacin preparation |
Oct 29, 2019
(Expired) | Bayer Hlthcare |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Bayer Hlthcare |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US5849752 | Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification |
Dec 05, 2016
(Expired) | Bayer Hlthcare |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US6548079 | Moxifloxacin formulation containing common salt |
Jul 25, 2020
(Expired) | Bayer Hlthcare |
| Moxeza | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Harrow Eye |
| Moxeza |
US5607942 (Pediatric) | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Sep 04, 2014
(Expired) | Harrow Eye |
| Moxeza | US6716830 | Ophthalmic antibiotic compositions containing moxifloxacin |
Sep 29, 2019
(Expired) | Harrow Eye |
| Moxeza |
US6716830 (Pediatric) | Ophthalmic antibiotic compositions containing moxifloxacin |
Mar 29, 2020
(Expired) | Harrow Eye |
| Moxeza | US7671070 | Method of treating ophthalmic infections with moxifloxacin compositions |
Sep 29, 2019
(Expired) | Harrow Eye |
| Moxeza |
US7671070 (Pediatric) | Method of treating ophthalmic infections with moxifloxacin compositions |
Mar 29, 2020
(Expired) | Harrow Eye |
| Moxeza | US8450311 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug | May 29, 2029 | Harrow Eye |
| Moxeza | US9114168 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug | May 29, 2029 | Harrow Eye |
| Vigamox | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Harrow Eye |
| Vigamox |
US5607942 (Pediatric) | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Sep 04, 2014
(Expired) | Harrow Eye |
| Vigamox | US6716830 | Ophthalmic antibiotic compositions containing moxifloxacin |
Sep 29, 2019
(Expired) | Harrow Eye |
| Vigamox |
US6716830 (Pediatric) | Ophthalmic antibiotic compositions containing moxifloxacin |
Mar 29, 2020
(Expired) | Harrow Eye |
| Vigamox | US7671070 | Method of treating ophthalmic infections with moxifloxacin compositions |
Sep 29, 2019
(Expired) | Harrow Eye |
| Vigamox |
US7671070 (Pediatric) | Method of treating ophthalmic infections with moxifloxacin compositions |
Mar 29, 2020
(Expired) | Harrow Eye |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Moxifloxacin Hydrochloride Generics
Several generic applications have been filed for Moxifloxacin Hydrochloride. The first generic version for Moxifloxacin Hydrochloride was by Teva Pharmaceuticals Usa and was approved on Feb 18, 2014. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Mar 2, 2023.
Given below is the list of companies who have filed for Moxifloxacin Hydrochloride generic.
1. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. This 400mg/250ml (1.6mg/ml) version comes by the name MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG/250ML (1.6MG/ML)
(reference standard) | solution | Prescription | INTRAVENOUS | N/A | May 5, 2017 |
2. NATCO
Natco Pharma Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Aug 31, 2015 |
3. MSN
Msn Laboratories Private Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Sep 22, 2017 |
4. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Oct 4, 2017 |
5. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Sep 28, 2018 |
6. APOTEX
Apotex Inc has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Jun 30, 2017 |
7. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Feb 13, 2019 |
8. TORRENT
Torrent Pharmaceuticals Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Discontinued | ORAL | N/A | Apr 3, 2014 |
9. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Feb 18, 2014 |
10. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Mar 30, 2020 |
11. LUPIN LTD
Lupin Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE
(reference standard) | solution/drops | Prescription | OPHTHALMIC | N/A | May 28, 2015 |
12. INDOCO
Indoco Remedies Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Indoco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Mar 6, 2015 |
13. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2017 |
14. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 2, 2023 |
15. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Mar 30, 2020 |
16. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Mar 4, 2014 |
17. CROSSMEDIKA SA
Crossmedika Sa has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Crossmedika Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Jan 14, 2016 |
18. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AT1 | Feb 10, 2021 |
19. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 400MG BASE | tablet | Prescription | ORAL | AB | Mar 4, 2014 |
20. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Moxifloxacin Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Nov 9, 2017 |